Press Releases

Press Releases

or

July 7, 2014
PARP inhibitor will be tested in disease-specific dose escalation cohorts to establish single-agent properties and preliminary anti-tumor activity BEIJING, China—July 7, 2014— BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune- oncology
March 18, 2014
CNCBD (China National Center for Biotechnology Development) Director Huang Jing visited BeiGene on March 13. About China National Center for Biotechnology Development China National Center for Biotechnology Development (abbreviated ass CNCBD in the following d description) is an organization
March 10, 2014
Beijing, China, March 10, 2014 — BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the upcoming presentation of two posters by company scientists and advisors at the American Association for Cancer Research
March 3, 2014
Eminent cancer researcher in immune-oncology and lymphoma to further strengthen company capabilities BEIJING, China, March 3, 2014 — BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the addition of Dr.
January 22, 2014
BJDA (Beijing Drug Administration) deputy director Luoluo Cong has visited BeiGene to hear the report made by R & D team about working projects of this company. After the meeting, Cong gave a high praise to the work of BeiGene. About Beijing Drug Administration BJDA is committed to implement
January 15, 2014
BeiGene announced today it has been selected as a Z-Park Top 10 up-and-coming company. The winning is due to the excellent performance of BeiGene in the year 2013, and its outstanding contribution in the field of international cooperation. About Z-Park Top 10 Series Award Zhongguancun Top 10 series
December 27, 2013
BeiGene announced today it has been selected as a finalist for Z-Park Top 10 series Award. This series award include 10 categories, every category will select out top 10 list. For this year, BeiGene has been selected as a finalist for Zhongguancun Park top 10 up-and-coming company, and Lusong Luo,